Ispire Technology Reports Strong Revenue Growth and Operational Improvements
News related to:Ispire Technology Inc · 2 min read
Ispire Technology Inc., a company specializing in vaping technology and precision dosing, reported strong financial results for the fourth quarter and fiscal year ended June 30, 2026. The company saw a significant increase in revenue, with Q4 revenue jumping 33% year-over-year and 43% sequentially to $26.7 million. This growth is attributed to the successful implementation of restructuring and investment strategies initiated more than a year ago.
Steven Przybyla, the President of Ispire, commented, "We believe the fourth quarter results mark an important inflection point for the company. The increase in revenue and the improvement in operating cash flow demonstrate that our efforts are starting to bear fruit. We are positioned for a fundamentally improved fiscal 2027."
The company's Malaysia manufacturing facility has now fully operational, and its Vapor ODM platform is entering the market. These initiatives are expected to expand the company's customer base and generate new revenue opportunities. Additionally, Ispire is advancing IKE Tech's proprietary age-gating technology toward commercialization, which could address significant unmet needs in the vaping market.
Ispire has also begun to diversify its business through a joint venture with Jincheng Pharma, entering the rapidly growing nicotine pouch market. This move is seen as a strategic step to capitalize on the expanding global market for nicotine alternatives.
In the fiscal year 2026, Ispire reported a decrease in revenue of 24.7% compared to the previous year, primarily due to lower sales of cannabis vaping hardware in the United States and reduced vaping product sales in Europe. However, the company managed to reduce its total operating expenses by 26%, leading to a significant improvement in its adjusted EBITDA, which increased by $4.8 million to $4.0 million.
Despite the overall decrease in revenue, Ispire's operating cash flow improved by $6.8 million, signaling progress toward cash flow positivity. The company held $19.3 million in cash and $803,000 in working capital at the end of the fiscal year.
Looking ahead, Ispire expects fiscal 2027 to be a transformative year, with the first full year of vapor and nicotine pouch production at its company-owned factories in Malaysia, major commercial developments within its IKE Tech joint venture, and continued investment in cutting-edge technologies.
These growth catalysts, each backed by a massive addressable market, are expected to drive the company's future performance. While the company remains focused on achieving positive cash flow, the improvements in financial metrics and the expansion into new markets are seen as positive indicators of the company's strategic direction.